Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted Average) (2016)

Amphastar Pharmaceuticals has reported Shares Outstanding (Diluted Average) over the past 4 years, most recently at $46.0 million for Q2 2016.

  • For Q2 2016, Shares Outstanding (Diluted Average) rose 2.5% year-over-year to $46.0 million; the TTM value through Jun 2016 reached $46.0 million, up 2.5%, while the annual FY2015 figure was $46709.0, N/A changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q2 2016 was $46.0 million at Amphastar Pharmaceuticals, down from $46.8 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $46.8 million in Q1 2016 and troughed at $38769.0 in Q1 2014.
  • A 4-year average of $24.9 million and a median of $38.8 million in 2013 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 99.9% in 2014 and later soared 114942.95% in 2015.
  • Year by year, Shares Outstanding (Diluted Average) stood at $38.9 million in 2013, then plummeted by 99.89% to $44644.0 in 2014, then grew by 4.63% to $46709.0 in 2015, then skyrocketed by 98313.58% to $46.0 million in 2016.
  • Business Quant data shows Shares Outstanding (Diluted Average) for AMPH at $46.0 million in Q2 2016, $46.8 million in Q1 2016, and $46709.0 in Q4 2015.